Evaluation of Right Ventricular overload by ^<123>I-MIBG, ^<123>I-BMIPP , and ^<99m>Tc-MIBI by Miyahara Yoshiyuki et al.
Acta Med. Nagasaki 47: 105-109
Evaluation of Right Ventricular overload by 123I-MIBG, 
 123I-BMIPP , and 99mTc-MIBI
Yoshiyuki MIYAHARA1), Satoshi IKEDA1), Tetsuro MATSUSHITA2), 
Takuya MORIMITSU1), Kyoji NISHIJIMA1), Shigeru KOHNO1)
1) Second Department of Internal Medicine, Nagasaki University School of Medicine 
2) Department of General Medicine, Nagasaki University School of Medicine
 It is important to evaluate the severity of right ventricu-
lar (RV) overload in patients with chronic pulmonary diseases 
or pulmonary thromboembolism because their prognosis de-
pend on the severity of RV overload. Various examination 
methods have been used to non-invasively evaluate the sever-
ity of RV overload. We evaluated the usefulness of recently 
developed novel radiopharmaceuticals 123I-MIBG, 123I-BMIPP, 
and 99mTc-MIBI) in patients with chronic respiratory diseases 
or pulmonary thromboembolism. Myocardial scintigraphy 
using 1231-MIBG revealed that the ratio of scintillation 
counts in the interventricular septum (IVS) to those in the 
left ventricle (LV) correlated negatively with the mean pul-
monary arterial pressure (MPAP), suggesting the presence 
of sympathetic neuropathy due to RV overload. Myocardial 
scintigraphy using 123I-BMIPP revealed that the ratio of 
scintillation counts in the RV to those in LV (RV/LV up-
take ratio) correlated with MPAP. There was a negative 
correlation between RV metabolic index [RVMI = (RV/LV 
ratio of 123I-BMIPP uptake) / (RV/LV ratio of 201T1 uptake)] 
and MPAP. These findings suggested the presence of RV 
overload-induced fatty acid metabolic disorder. 99iTc-MIBI 
allows the simultaneous performance of both cardiac pool 
scintigraphy and myocardial single photon emission com-
puted tomography. RV/LV ratio of 99"Tc-MIBI uptake corre-
lated with MPAP. Moreover, RV ejection fraction (RVEF) 
obtained by right cardiac pool scintigraphy correlated with 
the RVEF determined by the thermodilution method, sug-
gesting the usefulness of 99mTc-MIBI. 
 Our findings suggest that these radiopharmaceuticals are 
useful for evaluating the severity of RV overload in pa-
tients with chronic respiratory diseases or pulmonary 
thromboembolism, as well as for evaluating RV overload-
induced metabolic disorders. 
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Introduction
 Evaluation of the right heart system is important in 
patients with chronic pulmonary diseases or pulmonary 
vascular diseases because the severity of right ventricu-
lar (RV) overload correlates with prognosis. Invasive 
cardiac catheterization is mainly used to evaluate right 
cardiac function, and the procedure provides a high 
sensitivity and specificity. To date, various procedures 
have been used to evaluate non-invasively RV overload. 
These include echocardiography'-", electrocardiography5-" 
and nuclear medical examinations"'). 
 Myocardial scintigraphy using '0'T1 was developed 
initially to clinical evaluate of RV overload. Cohen et 
al.') first reported the usefulness of myocardial 
scintigraphy using 201 TI for the diagnosis of cor 
pulmonale. Subsequently, various studies confirmed 
the usefulness of 201T1-myocardial scintigraphy for the 
evaluation of the severity of RV hypertrophy (RVH)8-" 
 In recent years, myocardial scintigraphy using novel 
radiopharmaceuticals, 99m Tc-Sestamibi (99i' Tc-MIBI), 123 I-
metaiodobenzyl guanidine (123I-MIBG ), and 123I- 9 -meth 
yliodo phenyl pentadecanic acid (123I-BMIPP) has been 
developed to evaluate the left heart system. However, 
only few studies have previously evaluated the right 
heart system using these radiopharmaceuticals. In the 
present study, we evaluated the severity of RV overload 
in patients with chronic pulmonary diseases or pulmo-
nary vascular diseases using these radio pharmaceuticals. 
Based on our results, we discuss the usefulness of these 
radiopharmaceuticals for evaluating the right heart 
system.
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Methods
 Right heart cathetherization using Swan-Ganz balloon-
tipped catheters (TF 002H-7F, Baxter, California, USA) 
were performed via the jugular vein or the femoral vein. 
RVEF was measured using the thermodilution method 
and a REF-1 RVEF CO computer (Baxter, California, 
USA) 
  99mTc-MIBI , '23I-MIBG and 123I-BMIPP scintigraphy was 
performed within 1 week of right heart catheterization. 
A triple-headed gamma camera (PRISM 3000, Picker 
International Inc., Ohio, USA) equipped with a low-
energy, high resolution collimator was used for 
scintigraphy. On 123I-MIBG and 1231-BMIPP scintigraphy, 
single photon emission computed tomography (SPECT) 
imaging was obtained 15 min (early phase) and 4 h 
(late phase) after intravenous injection of 111 MBq 
radionuclides into the antecubital vein. SPECT images 
were acquired at an energy level of 159 keV, a window 
width of 20%, 40 sec per direction, with the step angle set 
at 5° x 24 steps. Data of a matrix size of 64 x 64 pixels 
and 360° were obtained. Following intravenous injec-
tion of 111MBq "'TI, SPECT was obtained a similar 
manner of 123I-MIBG and 123I-BMIPP scintigraphy, ex-
cept that the energy level was set at 75 keV for the 
201T1 scans . On 99mTc-MIBI scintigraphy, 740 MBq of 
99mTc-MIBI was bolus infused into the antecubital vein , 
and right heart pool scintigraphy was performed by the 
first-pass method using a multicristal-type portable 
gamma camera or a single-crystal gamma camera. Right 
ventricular ejection fraction was calculated from the 
end-diastolic count and end-systolic count. Regions of 
interest (ROI) were established at the RV, left ventri-
cle (LV) and interventricular septum (IVS) (Fig.1).
 Each parameter on scintigraphy were calculated from 
scintillation counts using the following equations: 
IVS/LV uptake ratio (%) = ROI 4 / (ROI 5 + ROI 6 + 
ROI 7) x 100 
RV/LV uptake ratio (ROI 1 + ROI 2 + ROI 3)/ 
(ROI 5 + ROI 6 + ROI 7) x 100 
RV metabolic index (RVMI) = (RV/LV ratio of 123I-BMIPP 
uptake / RV/LV ratio of 201T1 uptake)
1. 123I-MIBG
 It is considered that the uptake, storage, and release 
of 123I-MIBG, a norepinephrine analog, are qualitatively 
similar to those of norepinephrine in the sympathetic 
nerve ending. Therefore, the level of 123I-MIBG accu-
mulation reflects cardiac sympathetic nerve function. 
 We performed 123I-MIBG myocardial scintigraphy in 20 
patients with chronic pulmonary diseases or pulmonary 
vascular diseases (Table 1). Our results showed a nega-
tive correlation between the mean pulmonary arterial 
pressure (MPAP) and the IVS/LV ratio of 123I-MIBG up-
take (r=-0.78, p<0.01) (Fig. 2)12). Previous studies reported 
that the severity of RVH could generally be evaluated by 
201T1-myocardial scintigraphy based on the RV/LV ratio 
of scintillation counts, which correlated positively with 
the severity of RV overload"". Since the radioactivity 
of 123I-MIBG decreases with the severity of RV overload, 
which is in contrast to 201T1, it is often difficult to estab-
lish ROIs in the RV. Thus, we used the IVS/LV ratio of 
'23I-MIBG uptake to evaluate RV in this study . In con-
trast, ROIs are difficult to establish in the RV of pa-
tients with mild RV overload during 201T1-myocaridal 
scintigraphy. These findings suggested that the indi-
ces used in our study were useful for evaluating the 
severity of RV overload because they could be evalu-
ated easily and accurately.
Table 1 Characteristics of patients
Fig. 1 Schematic diagram of regions of interest (ROI). ROIs 
were established on RV free wall (No. 1, 2, 3), interventricular 
septum (IVS, No. 4), and LV free wall (No. 5, 6, 7). RV: right 
ventricle, LV: left ventricle.
                 Mean ± SD 
Sex (male/female) 10/10 
 Age (years) 61.8±2.5 
  PaO2 (ton) 71.0±2.2 
 PaCO2 (torn) 37.6±1.2 
  %VC (%) 86.0±7.0 
 FEV1.o% (%) 61.8±4.9
Pa02, partial pressure of oxygen; PaCO2, partial pressure of 
carbondioxide; %VC, % vital capacity; FEV1.0%, % forced 
expiratory volume in is
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Fig. 2 Correlation between the IVS/LV uptake ratio determined 
by 123I-MIBG image and MPAP. MPAP: mean pulmonary arte-
rial pressure.
 Previous studies concluded that /9 -adrenoreceptors 
are downregulated in patients with heart failure, result-
ing in reduced accumulation of 123I-MIBG'3.15'. Yoshie et 
al."' used rats with monocrotaline-induced pulmonary 
hypertension and showed that the level of (3 -adrenor 
eceptor decreased with increased severity of pulmo-
nary hypertension. Furthermore, Sakamaki et al."' re-
ported that myocardial sympathetic neuropathy was 
induced by excessive systemic sympathetic nerve ac-
tivity based on a lower heart/mediastinum activity of 
 '23I-MIBG , although plasma norepinephrine levels were 
higher in patients with chronic obstructive pulmonary 
diseases than in the controls. Therefore, our data also 
suggested that cardiac sympathetic neuropathy could 
be induced by chronic RV overload.
2. 123I-BMIPP
 Fatty acids and glucose are major energy sources for 
cardiac muscle. The energy efficiency of fatty acid /9 -
oxidation is high, and more than 80% of its energy sub-
strate depends on fatty acid metabolism. Since myocar-
dial fatty acid metabolic imaging facilitates the evalua-
tion of myocardial metabolism, this procedure is useful 
for elucidating the pathological conditions in various 
heart diseases. 123I-BMIPP is a radiopharmaceutical de-
veloped to evaluate myocardial fatty acid metabolism 
by myocardial scintigraphy. 
 201 T 1 and 123 I-BMIPP myocardial scintigraphy was 
performed in 46 patients with chronic pulmonary dis-
eases or pulmonary vascular diseases (Table 2). The 
RV/LV uptake ratio of 1231-BMIPP and MPAP showed 
a positive correlation (r=0.67, p<0.01) (Fig. 3, left)"'.
Since the RV visualized by 123I-BMIPP-myocardial 
scintigraphy was similar to that by ... TI-myocardial 
scintigraphy, the severity of RV overload was favora-
bly evaluated by 123I-BMIPP-myocardial scintigraphy. 
On 123I-BMIPP imaging, RV fatty acid metabolism 
seemed to be enhanced because of RVH. Therefore, 
the RVMI was calculated to exclude the influence of 
RVH. The results showed a negative correlation be-
tween RVMI and MPAP (r=-0.50, p<0.01) (Fig. 3, right)"'. 
In this regard, Kim et al."' suggested that 123I-BMIPP 
uptake in the RV decreased in patients with severe 
RVH, in which the RV was clearly depicted by 201T1-
myocardial scintigraphy, demonstrating the presence 
of fatty acid metabolic disorder. In addition, the level 
of 123I-BMIPP uptake in the IVS and in the free walls 
near the IVS in the LV, not in the RV, correlated with 
the severity of pulmonary hypertension, suggesting 
the presence of myocardial metabolic disorder in these 
regions20'. Thus, the decrease in RVMI associated with 
the severity of RV overload suggests the presence of 
RV overload-induced fatty acid metabolic disorder in 
the RV.
Table 2 Characteristics of patients
                 Mean±SD 
Sex (male/female) 26/20 
 Age (years) 64.0±11.8 
  Pa02 (tort) 74.0±18.5 
 PaCO2 (tort) 42.6±11.3 
  %VC (%) 80.0±24.8 
 FEV1.o% (%) 62.7±2.8
Abbreviations as in Tablet.
Fig. 3 Correlation between MPAP and the RV/LV uptake ratio 
of 123I-BMIPP (left), and RVMI (right). MPAP: mean pulmonary 
arterial pressure, RVMI: right ventricular metabolic index.
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3. 99mTc-MIBI
  99mTc-MIBI , which has excellent radiophysical proper-
ties such as a short half-life of 6 hours and gamma 
ray energy of 140 keV, is suitable for scintigraphy and 
SPECT. Furthermore, cardiac pool scintigraphy and 
myocardial SPECT can be performed simultaneously 
using 99mTc-MIBI. In 23 patients with chronic pulmo-
nary diseases or pulmonary vascular diseases (Table 3), 
we compared 99mTc-MIBI-myocardial scintigraphy with 
both right cardiac pool scintigraphy, using the first-
pass method, and myocardial SPECT211. The RV/LV 
ratio of 99mTc-MIBI uptake correlated positively with 
MPAP (r=0.81, p<0.01, Fig. 4, left)21> 99mTc-MIBI dif-
fuses passively, and binds to the mitochondria in myo-
cardial cells after its uptake in the myocardium. In com-
parison, 201T1 accumulate in the myocardium through an 
active transport process involving the Na-K pump. 
Since the half-life of 99mTc is shorter than that of 201T1, 
the dose of 99mTc-MIBI can be increased to a level 
more than five times larger than that of 201T1, and the 
higher radionuclide energy facilitates the acquisition of 
qualitatively more useful scintigrams. Moreover, 99mTc-
MIBI-myocardial scintigraphy can be used more safely 
than 201T1-myocardial scintigraphy because the dose of 
exposure is lower in 99m Tc-MIBI than in 201 T 122' . 
Furthermore, the RVEF obtained by right cardiac pool 
scintigraphy using 99mTc-MIBI correlates with the RVEF 
obtained by right cardiac catheterization using the 
thermodilution method (r=0.68, p<0.01, Fig. 4, right)211. 
Combined together, these findings suggest that 99mTc-
MIBI-myocardial scintigraphy facilitates the simultane-
ous evaluation of RVEF and the severity of RVH, to-
gether with the evaluation of the right heart system.
Fig. 4 Left: correlation between MPAP and RV/LV uptake 
ratio determined by 99mTc-MIBI image. Right: correlation be-
tween right ventricular ejection fraction measured by right 
cardiac catheterization and right heart pool scintigraphy 
using 99mTc-MIBI. MPAP: mean pulmonary arterial pressure .
Conclusions
 The respective radiopharmaceuticals correlated sig 
nificantly with pulmonary arterial pressure. Furthermore , 
 123I-MIBG facilitated the evaluation of cardiac sympa -
thetic nerve function in RV overload, whereas 123I-
BMIPP facilitated the evaluation of RV fatty acid me-
tabolism. Moreover, another advantage of 99mTc-MIBI 
was that it facilitates the simultaneous evaluation of 
right cardiac function and morphological changes after 
administration of a single radiopharmaceutical . Using 
these radiopharmaceuticals the severity of RV overload 
can be evaluated non-invasively from different per-
spectives.
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